Patients with Opioid Use Disorder Choosing Treatment with Extended-Release Naltrexone: A 6-Month Naturalistic Study
This study demonstrated high retention rates, decreased opioid use, and low use of other illicit substances and alcohol. Participants also reported low cravings for heroin and high treatment satisfaction. Completion of the full 24-week treatment resulted in lower opioid use and increased treatment satisfaction compared to those who discontinued treatment before 24 weeks. The observed higher retention and reduced opioid use, compared to other studies, may be attributed to participants' strong motivation for opioid abstinence facilitated by XR-NTX treatment.
Authors
- Jon Mordal (ORCID: https://orcid.org/0009-0006-9868-2450)
- Ida Halvorsen Brenna
- Else‐Marie Løberg (ORCID: https://orcid.org/0000-0002-4243-5067)
- Kristin Klemmetsby Solli (ORCID: https://orcid.org/0000-0003-4622-2947)
- Lars Tanum (ORCID: https://orcid.org/0000-0003-4001-6325)
- Jūratė Šaltytė Benth (ORCID: https://orcid.org/0000-0003-4199-2272)
- Bente Margrethe Weimand (ORCID: https://orcid.org/0000-0003-1800-7318)
- Karin Merethe Waleur
Institutions
- OsloMet – Oslo Metropolitan University (NO)
- University of Oslo (NO)
- Akershus University Hospital (NO)
- Haukeland University Hospital (NO)
- University of South-Eastern Norway (NO)
- Sykehuset i Vestfold (NO)
- University of Bergen (NO)
- Norwegian University of Life Sciences (NO)
Publication Details
- Journal
- European Addiction Research
- Published
- 2024-11-04
- DOI
- https://doi.org/10.1159/000541431
- Citations
- 7
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.80